Article

Bone marrow microenvironmental changes in aged mice compromise V(D)J recombinase activity and B cell generation

Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA.
Seminars in Immunology (Impact Factor: 6.12). 11/2005; 17(5):347-55. DOI: 10.1016/j.smim.2005.05.012
Source: PubMed

ABSTRACT B cell generation and immunoglobulin (Ig) diversity in mice is compromised with aging. Our recent work sought to understand mechanism(s) that contribute to reduced B cell production in aged mice. Using in vivo labeling, we found that reduction in marrow pre-B cells reflects increased attrition during passage from the pro-B to pre-B cell pool. Analyses of reciprocal bone marrow (BM) chimeras reveal that the production rates of pre-B cells are controlled primarily by microenvironmental factors, rather than intrinsic events. To understand changes in pro-B cells that could diminish production of pre-B cells, we evaluated rag2 expression and V(D)J recombinase activity in pro-B cells at the single cell level. The percentage of pro-B cells that express rag2 is reduced in aged mice and is correlated with both a loss of V(D)J recombinase activity in pro-B cells and reduced numbers of pre-B cells. Reciprocal BM chimeras revealed that the aged microenvironment also determines rag2 expression and recombinase activity in pro-B cells. These observations suggest that extrinsic factors in the BM that decline with age are largely responsible for less efficient V(D)J recombination in pro-B cells and diminished progression to the pre-B cell stage. These extrinsic factors may include cytokines and chemokines derived from BM stromal cells that are essential to the development of B cell precursors. The changes during aging within the BM hematopoietic microenvironment most likely are linked to the physiology of aging bone. Bone degrades with age (osteoporosis) due to decreased formation of new bone by osteoblasts. Marrow stem cells (MSC) are considered the progenitor of both adipocytes, osteoblasts and hematopoietic stromal cells and a controlled reciprocal regulation exists of osteoblast versus adipocyte differentiation; with age adipocytes increase, and osteoblast decrease. It is possible that stromal cell generation from MSC is compromised during aging. Currently, understanding of BM microenvironmental factors that regulate rag gene expression is very limited. However, as early progenitors differentiate, it is increasing clear that a limited set of transcription factors (e.g. ikaros, PU.1, E2A, EBF, pax5) regulate B-lineage specific genes, and that expression and stability of these factors is responsive to the microenvironment. Current and future work by several groups will strive to understand mechanisms that regulate these factors and how aging impacts these regulatory circuits.

Download full-text

Full-text

Available from: Rachel M Gerstein, Aug 25, 2015
0 Followers
 · 
144 Views
  • Source
    • "This is most readily observed as a decline in the number of pre-B cells within the bone marrow, but more recent studies also indicate that early B cell precursors, including common lymphoid progenitors and pro-B cells, are also adversely affected by the aging process (Riley et al., 1991; Stephan et al., 1996; Sherwood et al., 1998; Miller et al., 2003; Van der Put et al., 2003; Labrie et al., 2005). The consequences of diminished B cell development in old mice are not well characterized, but may contribute to alterations in B cell longevity (Johnson et al., 2002; Kline et al., 1999; Labrie et al., 2005) and composition of the B cell receptor repertoire (Klinman et al., 1997; Wilson et al., 2005) during senescence. Whether similar alterations in B cell development are observed in humans is speculative; however, naïve B cells are reduced in number in the periphery in old age (Nunez et al., 1996; Huppert et al., 1999; Ogawa et al., 2000; Rossi et al., 2003) Previously, it has been shown that old murine bone marrow cells deficient in surface IgM, when used as a source of pre-B cells, generated new B cells with substantial changes in the antibody repertoire to the phosphorylcholine (PC) epitope (Klinman et al., 1997). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The bone marrow of old adult mice ( approximately 2 years old) has reduced B lymphopoiesis; however, whether the B1 pathway in adult bone marrow is also compromised in senescence is not known. Herein, we show that phenotypic (IgM(-)Lin(-)CD93(+)[AA4.1(+)] CD19(+)B220(low/-)) B1 progenitors are retained in old bone marrow even as B2 B cell precursors are reduced. Moreover, B1 progenitors from both young adult and old mice generated new B cells in vitro enriched for CD43 expression, likely due to their activation, and exhibited increased lambda light chain usage and diminished levels of kappa light chain expression. B1 progenitors were shown to have lower surrogate light chain (lambda5) protein levels than did B2 pro-B cells in young mice and these levels decreased in both B1 and B2 precursor pools in old age. These results indicate that the B1 B cell pathway persists during old age in contrast to the B2 pathway. Moreover, B1 B cell progenitors generated new B cells in the adult bone marrow that have distinct surface phenotype and light chain usage. This is associated with decreased surrogate light chain expression, a characteristic held in common by B1 progenitors as well as B2 precursors in old mice.
    Mechanisms of ageing and development 07/2009; 130(6):401-8. DOI:10.1016/j.mad.2009.04.001 · 3.51 Impact Factor
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gene therapy can be classified according to the vector used for gene therapy and the transgene that will be expressed as a result of the gene therapy. One consideration for gene therapy is that certain vectors have larger capacities than others to incorporate genes. The second consideration is the duration of therapy, which depends upon the immune response after delivery of the therapy. Therapy duration usually exhibits a reciprocal relationship to therapy immunogenicity. A third consideration is safety. This is related both to the immunogenicity and adverse effects of potential integration. These factors are shown in Table 1. Advances to enable gene integration with safety have been carried out using a “suicide” gene, such as thymidine kinase (TK) that can be upregulated to eliminate cells in which the transgene has integrated into an adverse position in the genome.
Show more